Specific binding proteins and uses thereof

Details for Australian Patent Application No. 2002311919 (hide)

Owner Ludwig Institute for Cancer Research

Inventors Scott, Andrew Mark; Cavenee, Webster K.; Nice, Edouard collins; Collins, Peter; Renner, Christoph; Ritter, Gerd; Old, Lloyd J.; Burgees, Anthony Wilks; Jungbluth, Achim; Stockert, Elisabeth; Johns, Terrance Grant; Panousis, Con; Huang, Huei-Jen

Agent Madderns

Pub. Number AU-B-2002311919

PCT Number PCT/US02/15185

PCT Pub. Number WO2002/092771

Priority 60/290,410 11.05.01 US; 60/326,019 28.09.01 US; 60/342,258 21.12.01 US

Filing date 13 May 2002

Wipo publication date 25 November 2002

Acceptance publication date 8 February 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 60/290,410 11.05.01 US; 60/326,019 28.09.01 US; 60/342,258 21.12.01 US

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2002311919

8 February 2007 Application Accepted

  Published as AU-B-2002311919

22 March 2007 Corrigenda

  Applications Accepted - Name Index Under the name Ludwig Institute for Cancer Research, Application No. 2002311919, under INID (72) corect the inventor names to read Scott, Andrew Mark; Cavenee, Webster K.; Nice, Edouard collins; Collins, Peter; Renner, Christoph; Ritter, Gerd; Old, Lloyd J.; Burgess, Anthony Wilks; Jungbluth, Achim; Stockert, Elisabeth; Johns, Terrance Grant; Panousis, Con and Huang, Huei-Jen.

7 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002311920-ORAL CARE CONFECTIONERY COMPOSITIONS

2002311918-METHOD FOR FORMING ELECTRICALLY CONDUCTIVE IMPREGNATED FIBERS AND FIBER PELLETS